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S. ep idmid i s  9142 were isolated, which were completely biofilm 
negative. Linkage of transposon insertions and phenotypic changes 
was proven by phage transduction. Primary attachment of the mu- 
tants to polystyrene was unchanged compared to wildtype, however, 
formation of large cell clusters by the mutants was completely abol- 
ished. The mutants did not produce detectable amounts of the spe- 
cific antigen proving its function in intercellular adhesion of S. epider- 
midis cells essential for b i o f h  accumulation. F'urfication and struc- 
tural analysis of the antigen revealed a polysaccharide mainly com- 
posed of B-1,6-linked 2-amino-2-deoxy-D-glucopyranosid residues. 
80-85% of the sugar residues are N-acetylated whereas the rest 
is non-N-acetylated and positively charged. Due to its function 
we refer to the polysaccharide as polysaccharide intercellular ad- 
hesin (PIA). There was a statistical significant association between 
biohlm-production and PIA expression in 179 clinical S. epidermidis 
isolates. A linear association between the amount of PIA produced as 
detected by ELISA-inhibition and the amount of biofilm produced 
was established for 49 S. epidermidis strains representing a continuum 
h m  biofilm-negative to strongly biofh-producing (r = 0.81, p < 
0,001). Apparently PIA is important for b i o f h  accumulation of the 
majority of clinical S. epidermidis isolates. 
dents suffering b m  staphylococcal infection associated with sta- 
ble orthopedic devices. The patients were assigned to receive ei- 
ther ciprofloxacin/rifampin or ciprofloxacin/placebo. Twenty-four 
patients fully completed the trial. The cure rate was 12/12 in the 
former and 7/12 in the latter group (p = 0.019). Nine patients 
dropped out, mainly due to adverse events. Seven of 9 drop-out pa- 
tients were subsequently treated with rifampin-combinations, partly 
in reduced dose. Six of them were cured, among them 5 patients 
without removal of the device. 
Conclusion: Orthopedic device-related infections due to ri- 
fampin and ciprofloxacin susceptible staphylococci can be cured 
without removal of the device, given the implant is stable, an initial 
dkbridement is performed, and the patient tolerates long-term (3-6 
months) therapy. 
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I S161 1 Anti-lnfectiie Coatings Can Decrease the Risk of 
Infection Associated with Foreign Bodies 
R. Sherertz. &an Gray School $Medicine, Winston-Salem, NC 
27157, USA 
In the last 20 years there have been increasingly frequent attempts 
to use anti-infective coatings to prevent foreign body infections. 
In animal models (mouse, rat, rabbit) using staphylococci as in- 
fecting organisms efficacious anti-mfective coatings have included 
penicillin G, dicloxach, clindamycin, fusidic acid, chlorhexidine 
(Ch), silver sulfadiazine (AgS), minocycline (M), rifampin (R), and 
benzalkonium chloride as well as certain combinations AgS/Ch, 
M/R, M/EDTA. Ineffective coatings in animal models include 
ciprofloxacin, cefotaxime, Ag and TDMAC. In vivo half-lifes of 
successful coatings range from t 6  h to 2 4  days. In vitm zones of 
inhibition z15 mm by a modhed Kirby-Bauer method have been 
predictive of anti-infective coating efficacy both in animal models 
and in clinical trials. M/R and AgS/Ch coatings have both been 
demonstrated to have efficacy in randomized c h c a l  trials. Ulti- 
mately the optimal coahng must have broad spectrum antimicrobial 
activity and possibly other qualities as well, such as anti-inflammatory 
or anti-thrombotic capabhties. Additional studies are necessary to 
understand the optimal use of anti-mfective coatings and whether 
large scale use will lead to problems with resistance. 
I S162 I Antibiotic Therapy of Staphylococcal 
W. Zimmerli. Division In+ct. Diseases, University Hospitals, Basel, 
Swi t zdand  
Device-related infections persist without treatment and rarely re- 
spond to antimicrobial therapy without removal of the implant. 
This may be due to resistance of adherent bacteria to phagocyto- 
sis and to most antibiotics. A special problem are orthopedic de- 
vice-related infections because these implants cannot easily be re- 
moved. Observational studies showed that despite prolonged (4-6 
weeks) iv-treatment with betalactam antibiotics, the failure rate with 
retention of the device is between 32% and 82%. In contrast, treat- 
ment with quinolone/rifampin combinations showed lower fail- 
ure rates (18-38%) in 2 uncontrolled studies. We therefore con- 
ducted a double blind, randomized clinical trial involving 33 pa- 
Device-Related Infections 
I s163 I Antibiotic Resistance: Quo vadis? 
E Baquero. E 
No abstract available. 
1 S 164 1 Challenges for Future Vaccines 
PH. Lambert. C H  
No abstract available. 
Advances in herpes virus infections 
I S165 I Prevention of HSV transmission: chemotherapy 
or vaccination, what seems approachable 
L. Corcy. University $ Washington G. Fred Hutchinson Cancer Research 
C e n t q  Seattle, WA, USA 
Prevention of HSV transmission is the major scientific question to 
be solved in HSV immunobiology. Tramtionally t h i s  approach has 
best been developed by vaccination. However, several aspects about 
herpes simplex virus lnfection make vaccination a potentially &I- 
cult goal. This includes the very short time between viral inoculation 
on mucosal surfaces and sequestration of the virus within the pro- 
tected site of the neuron. Recent studies with very potent subunit 
vaccines have given less than optimal prevention. Another approach 
to prevention is the use of chemotherapeutic approaches to prevent 
HSV reactivation at mucosal sites. Recent studies have indicated that 
HSV reactivates much more frequently than previously appreciated. 
In immuno-competent persons, HSV DNA is found on mucosal 
surfaces on 25-30% of days. All available data suggest that such HSV 
DNA is infectious and associated with replicating virions in epithe- 
lial cells. These data indicate that a chemotherapeutic approach in 
which daily suppression of viral replication by an antiviral may be 
a useful approach for preventing the transmission of HSV infection. 
This may have important implications with respect to management 
of HSV in pregnancy, the interaction between HSV and HIV in HIV 
infected persons as well as attempting to reduce the transmission of 
HSV between sexual partners. These issues will be discussed. 
